Heikki Kouru

Glycosylated fibronectin as a first trimester marker for gestational diabetes.

Journal: Archives of gynecology and obstetrics

Published: January 03, 2020

First trimester combined screening biochemistry in detection of congenital heart defects.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: April 24, 2018

Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: November 22, 2017

A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus.

Journal: Fetal diagnosis and therapy

Published: October 30, 2017

A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: June 01, 2017

Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia.

Journal: Metabolism: clinical and experimental

Published: February 07, 2017

First trimester prediction of gestational diabetes mellitus: A clinical model based on maternal demographic parameters.

Journal: Diabetes research and clinical practice

Published: September 05, 2016

Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: June 24, 2016

First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.

Journal: Metabolism: clinical and experimental

Published: May 13, 2014

Glycosylated fibronectin as a first trimester marker for gestational diabetes.

Glycosylated fibronectin as a first trimester marker for gestational diabetes.

First trimester combined screening biochemistry in detection of congenital heart defects.

First trimester combined screening biochemistry in detection of congenital heart defects.

Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland.

Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland.

A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus.

A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus.

A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.

A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.

Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia.

Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia.

First trimester prediction of gestational diabetes mellitus: A clinical model based on maternal demographic parameters.

First trimester prediction of gestational diabetes mellitus: A clinical model based on maternal demographic parameters.

Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.

Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.

Performance of third-trimester combined screening model for prediction of adverse perinatal outcome.

Performance of third-trimester combined screening model for prediction of adverse perinatal outcome.

Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.

Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.

First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.

First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.